Fleming Laboratories Profile
Key Indicators
- Authorised Capital ₹ 45.00 Cr
as on 06-08-2024
- Paid Up Capital ₹ 44.02 Cr
as on 06-08-2024
- Company Age 32 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 51.03 Cr
as on 06-08-2024
- Satisfied Charges ₹ 34.23 Cr
as on 06-08-2024
- Revenue 13.37%
(FY 2023)
- Profit 15.27%
(FY 2023)
- Ebitda 12.82%
(FY 2023)
- Net Worth 24.32%
(FY 2023)
- Total Assets 8.41%
(FY 2023)
About Fleming Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 45.00 Cr and a paid-up capital of Rs 44.02 Cr.
The company currently has active open charges totaling ₹51.03 Cr. The company has closed loans amounting to ₹34.23 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Fleming Laboratories Limited India are Niranjan Chittaranjan as CFO and Navneet Kaur as Company Secretary. Shivakumar Balakrishnan, Jeyamuruga Manoharan, Nadar Veluchamy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230TG1992PLC014560
- Company No.
014560
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Jul 1992
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Fleming Laboratories Limited offer?
Fleming Laboratories Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API.
Who are the key members and board of directors at Fleming Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jeyamuruga Manoharan  | Managing Director | 20-Nov-2014 | Current |
| Niranjan Chittaranjan | CFO | 20-Nov-2014 | Current |
| Navneet Kaur | Company Secretary | 09-Feb-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nadar Veluchamy | Director | 11-Aug-2016 | Current |
| Shivakumar Balakrishnan | Director | 23-Aug-2023 | Current |
| Nithyagovind | Nominee Director | Current | |
| Kesavamuralidhar Vadakattu | Director | 25-Oct-2019 | Current |
Financial Performance and Corporate Structure Insights of Fleming Laboratories.
Fleming Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.37% increase. The company also saw a substantial improvement in profitability, with a 15.27% increase in profit. The company's net worth Soared by an impressive increase of 24.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fleming Laboratories?
In 2023, Fleming Laboratories had a promoter holding of 55.00% and a public holding of 45.00%. The company had 1 Joint Venture and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Scires Technologies Private LimitedActive 3 years 10 monthsShivakumar Balakrishnan and Jeyamuruga Manoharan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Sep 2022 | ₹15.00 Cr | Open |
Others Creation Date: 10 Feb 2021 | ₹3.03 Cr | Open |
Others Creation Date: 29 Sep 2020 | ₹33.00 Cr | Open |
How Many Employees Work at Fleming Laboratories?
Fleming Laboratories has a workforce of 271 employees as of Aug 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fleming Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fleming Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
